Clarivate(CLVT)

Search documents
Clarivate and the Chinese Academy of Sciences Release Annual Collaborative Report to Identify 125 Research Fronts
Prnewswire· 2024-11-27 13:00
Revealing highly active specialties in sciences and social sciencesLONDON, Nov. 27, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, and the Chinese Academy of Sciences (CAS) today released 2024 Research Fronts™, identifying the most dynamic and rapidly growing specialties in sciences and social sciences. This marks the eleventh annual collaboration between the two organizations, with the report launched at a ceremony held in Beijing today.The report ...
BioWorld by Clarivate Highlights Gaps in Women's Health Research and Investment in New Special Series
Prnewswire· 2024-11-21 08:00
New seven-part series explores disparities in care, funding and innovation impacting half the world's populationLONDON, Nov. 21, 2024 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has launched its new special series, 'Healing the Health Divide.' This seven-part series sheds light on the persistent disparities in women's health research, funding, and treatment.Women make up half of the global population, yet their health remains co ...
Clarivate Reveals Highly Cited Researchers 2024 List
Prnewswire· 2024-11-19 08:00
Prioritizing research integrity with enhanced filters to address publication and citation manipulation LONDON, Nov. 19, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today revealed its 2024 list of Highly Cited Researchers™ – influential researchers at universities, research institutes and commercial organizations around the world who have demonstrated significant and broad influence in their field(s) of research. Analysts at the Institute for Scie ...
New Report from Clarivate and Healthcare Executive Explores Mainland China's Biopharma Revolution and Increasing Global Influence
Prnewswire· 2024-11-18 08:00
New report analyses Mainland China's transformation into a global biopharma powerhouse, with key insights for international stakeholdersLONDON, Nov. 18, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, in partnership with Healthcare Executive, published by the China Pharmaceutical Enterprises Association, today announced the release of a new report, A Decade of Innovation, A Decade to Come.Over the past decade, Mainland China's biopharmaceutical sector ...
Clarivate Healthcare Business Insights Unveils 2023 Revenue Cycle Award Winners
Prnewswire· 2024-11-13 08:00
Recognizing Roper St. Francis Healthcare, Bon Secours Mercy Health, and Bronson Methodist Hospital for excellence in Physician and Hospital GroupsLONDON, Nov. 13, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, announced the 2023 winners of the Clarivate Healthcare Business Insights™ annual Revenue Cycle Awards. Now in its 12th year, the Revenue Cycle Awards recognize U.S.-based healthcare organizations for exceptional performance on revenue cycle KPI ...
Clarivate Publishes 2023 Sustainability Report
Prnewswire· 2024-11-12 08:00
LONDON, Nov. 12, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has today published its fourth annual sustainability report, showcasing its commitment to sustainability and the United Nations Sustainable Development Goals (SDGs). In 2023, Clarivate was shortlisted for the SDG Pioneer Award at the Thomson Reuters Responsible Business Awards. Newsweek recognized Clarivate as one of "America's Greatest Workplaces for Diversity for 2024" and "America's ...
Clarivate: Downgrade To Hold As Growth May Take A Long Time To Recover
Seeking Alpha· 2024-11-08 13:04
I recommended a buy rating for Clarivate PLC (NYSE: CLVT ) when I wrote about it on 8 th August, as I believed the upside was attractive given the organic growth recovery story was well I consider an investment ideal if it performs its core business in a sector projected to experience structural (organic) growth in excess of GDP growth over the next 5-10 years; profits from sustainable competitive advantages that translate into attractive unit economics; In the hands of competent, ethical, and long-term thi ...
Clarivate Launches New Sustainability Research Solution
Prnewswire· 2024-11-07 08:00
ProQuest One Sustainability offers a transdisciplinary research experience and features AI-powered ProQuest Research AssistantLONDON, Nov. 7, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of ProQuestTM One Sustainability. The new solution is an expansive, curated, multi-format content collection designed to meet the growing demand for sustainability curricula across research, teaching and learning.Developed in collaborati ...
Clarivate(CLVT) - 2024 Q3 - Earnings Call Transcript
2024-11-06 20:07
Clarivate Plc (NYSE:CLVT) Q3 2024 Earnings Conference Call November 6, 2024 9:00 AM ET Company Participants Mark Donohue - Vice President of Investor Relations Matti Shem Tov - Chief Executive Officer Jonathan Collins - Chief Financial Officer Conference Call Participants Owen Lau - Oppenheimer David Paige - RBC Toni Kaplan - Morgan Stanley Andrew Nicholas - William Blair Manav Patnaik - Barclays Shlomo Rosenbaum - Stifel Peter Christiansen - Citi George Tong - Goldman Sachs Colton Feldmann - Jefferies Oper ...
Clarivate (CLVT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
ZACKS· 2024-11-06 15:35
Clarivate PLC (CLVT) reported $622.2 million in revenue for the quarter ended September 2024, representing a year-over-year decline of 3.9%. EPS of $0.19 for the same period compares to $0.21 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $640.01 million, representing a surprise of -2.78%. The company has not delivered EPS surprise, with the consensus EPS estimate being $0.19. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- an ...